• Search
  • Featured ▾
  • Following
  • Upload
  • Account
  • Search

    • Phenotypic Drug Discovery – The Move from High Content to High Impact Screening

    Posted by

    SELECTBIO

    2,332 views

    |

    October 19, 2016

  • Share
  • Add to Playlist
  • Bookmark

    • Beverley Isherwood, Innovative Medicines, AstraZeneca, UK, speaking at High Content & Phenotypic Screening 2016.

    Drug Discovery
    Up Next
    Autoplay
    video
    Play Video
    02:26
    Real Time Ex Vivo Chemosensitivity Assay for Pancreatic Adenocarcinoma | Oncotarget
    Oncotarget
    7 months ago
    Analytical TechniquesCancer ResearchCell ScienceDrug Discovery
    video
    Play Video
    00:14
    Creative Biolabs at the 5th Exosome Based Therapeutic Development Summit
    Biotech Videos
    3 months ago
    BiopharmaDrug Discovery
    video
    Play Video
    00:09
    Chilworth Vapour Ignition Testing
    Chilworth
    13 years ago
    Drug DiscoveryFlow Chemistry
    More Videos from SELECTBIO
    video
    Play Video
    32:34
    Current Pitfalls in Allergen Analysis
    SELECTBIO
    7 years ago
    Food and BeverageMass Spectrometry
    video
    Play Video
    34:58
    Emerging Toxins in Food and Feed
    SELECTBIO
    7 years ago
    Food and BeverageMass Spectrometry
    video
    Play Video
    32:04
    Food Safety Policies – Support, Opposition, and Ignorance
    SELECTBIO
    7 years ago
    Food and BeverageMass Spectrometry
    Playlists featuring SELECTBIO
    18
    video
    Play All
    Flow Chemistry Europe 2016
    SELECTBIO
    3
    video
    Play All
    Biodetection & Biosensors 2015
    SELECTBIO
    7
    video
    Play All
    Lab-on-a-Chip and Mircrofludics 2015
    SELECTBIO

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.